ENTA- Enanta Pharmaceuticals Inc

Name: Enanta Pharmaceuticals Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Enanta Pharmaceuticals Inc (ENTA) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ENTA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Luly Jay R.	858.0K	$13.16M	-
Other	Or Yat Sun	371.4K	$5.70M	-
Other	Luu Brendan	38.3K	$588.0K	-
Other	Kieffer Tara Lynn	30.6K	$469.7K	-
Other	Rottinghaus Scott T.	21.8K	$334.3K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 5, 2025	Capps Kathleen S.	See Remarks	Sell	323	$14.23	$4,596.29	-3.7%	-5.8%	-
Dec 5, 2025	Trout Harry R. III	See Remarks	Sell	542	$14.23	$7,712.66	-3.2%	-5.8%	-
Dec 5, 2025	Rottinghaus Scott T.69	Chief Medical Officer	Sell	798	$14.23	$11,355.54	-3.5%	-5.8%	-
Dec 5, 2025	Luu Brendan	Chief Business Officer	Sell	1,394	$14.23	$19,836.62	-3.5%	-5.8%	-
Dec 5, 2025	Kieffer Tara Lynn54	Chief Product Strategy Officer	Sell	2,106	$14.23	$29,968.38	-6.4%	-5.8%	-
Dec 5, 2025	Or Yat Sun59	Chief Scientific Officer	Sell	2,390	$14.23	$34,009.70	-0.6%	-5.8%	-
Dec 5, 2025	Luly Jay R.71	President And CEO	Sell	4,743	$14.23	$67,492.89	-0.5%	-5.8%	-
Dec 2, 2025	Capps Kathleen S.	See Remarks	Sell	207	$13.96	$2,889.72	-2.3%	+3.9%	-
Dec 2, 2025	Trout Harry R. III	See Remarks	Sell	380	$13.96	$5,304.80	-2.2%	+3.9%	-
Feb 12, 2025	Luly Jay R.71	President And CEO	Buy	45,000	$5.69	$256,050.00	+5.6%	-10.8%	+136.2%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC